The company claims that tests carried out through their device MyNeoShield can provide results within 4 hours on the spot compared to traditional techniques that take up to 24 hours.
Of the $10 billion worth market, standalone centres account for 48% market share, followed by hospital labs with 37% share and national chains with 5% share.
